Preliminary  ||| S:0 E:12 ||| JJ
study  ||| S:12 E:18 ||| NN
on  ||| S:18 E:21 ||| IN
combined  ||| S:21 E:30 ||| JJ
pharmacological  ||| S:30 E:46 ||| NN
and  ||| S:46 E:50 ||| CC
laser  ||| S:50 E:56 ||| NN
treatment  ||| S:56 E:66 ||| NN
in  ||| S:66 E:69 ||| IN
optic  ||| S:69 E:75 ||| JJ
pit  ||| S:75 E:79 ||| NN
serous  ||| S:79 E:86 ||| NN
maculopathy  ||| S:86 E:98 ||| NN
after  ||| S:98 E:104 ||| IN
literature  ||| S:104 E:115 ||| NN
review  ||| S:115 E:122 ||| VB
The  ||| S:122 E:126 ||| DT
pit  ||| S:126 E:130 ||| NN
of  ||| S:130 E:133 ||| IN
the  ||| S:133 E:137 ||| DT
optic  ||| S:137 E:143 ||| JJ
nerve  ||| S:143 E:149 ||| NN
head  ||| S:149 E:154 ||| NN
( ||| S:154 E:155 ||| -LRB-
ON ||| S:155 E:157 ||| NNP
)  ||| S:157 E:159 ||| -RRB-
is  ||| S:159 E:162 ||| VBZ
a  ||| S:162 E:164 ||| DT
rare  ||| S:164 E:169 ||| JJ
congenital  ||| S:169 E:180 ||| JJ
defect  ||| S:180 E:187 ||| NN
that  ||| S:187 E:192 ||| WDT
sometimes  ||| S:192 E:202 ||| RB
presents  ||| S:202 E:211 ||| VBZ
itself  ||| S:211 E:218 ||| PRP
with  ||| S:218 E:223 ||| IN
a  ||| S:223 E:225 ||| DT
maculopathy  ||| S:225 E:237 ||| NN
of  ||| S:237 E:240 ||| IN
various  ||| S:240 E:248 ||| JJ
neuroretinal  ||| S:248 E:261 ||| JJ
layers  ||| S:261 E:268 ||| NNS
for  ||| S:268 E:272 ||| IN
unknown  ||| S:272 E:280 ||| JJ
reason ||| S:280 E:286 ||| NN
.  ||| S:286 E:288 ||| .
This  ||| S:288 E:293 ||| DT
study  ||| S:293 E:299 ||| NN
was  ||| S:299 E:303 ||| VBD
focused ||| S:303 E:310 ||| VBN
,  ||| S:310 E:312 ||| ,
before  ||| S:312 E:319 ||| RB
and  ||| S:319 E:323 ||| CC
after  ||| S:323 E:329 ||| IN
pharmacological  ||| S:329 E:345 ||| NN
and  ||| S:345 E:349 ||| CC
parasurgical  ||| S:349 E:362 ||| JJ
treatment ||| S:362 E:371 ||| NN
,  ||| S:371 E:373 ||| ,
on  ||| S:373 E:376 ||| IN
the  ||| S:376 E:380 ||| DT
structural  ||| S:380 E:391 ||| JJ
and  ||| S:391 E:395 ||| CC
functional  ||| S:395 E:406 ||| JJ
visual  ||| S:406 E:413 ||| JJ
assessment  ||| S:413 E:424 ||| NN
in  ||| S:424 E:427 ||| IN
a  ||| S:427 E:429 ||| DT
patient  ||| S:429 E:437 ||| NN
with  ||| S:437 E:442 ||| IN
optic  ||| S:442 E:448 ||| JJ
pit  ||| S:448 E:452 ||| NN
maculopathy  ||| S:452 E:464 ||| NNS
( ||| S:464 E:465 ||| -LRB-
OPM ||| S:465 E:468 ||| NNP
) ||| S:468 E:469 ||| -RRB-
.  ||| S:469 E:471 ||| .
In  ||| S:471 E:474 ||| IN
order  ||| S:474 E:480 ||| NN
to  ||| S:480 E:483 ||| TO
achieve  ||| S:483 E:491 ||| VB
this  ||| S:491 E:496 ||| DT
the  ||| S:496 E:500 ||| DT
latest  ||| S:500 E:507 ||| JJS
generation  ||| S:507 E:518 ||| NN
of  ||| S:518 E:521 ||| IN
hi-tech  ||| S:521 E:529 ||| JJ
diagnostic  ||| S:529 E:540 ||| JJ
tests  ||| S:540 E:546 ||| NNS
were  ||| S:546 E:551 ||| VBD
used ||| S:551 E:555 ||| VBN
,  ||| S:555 E:557 ||| ,
such  ||| S:557 E:562 ||| JJ
as  ||| S:562 E:565 ||| IN
Spectral-Domain  ||| S:565 E:581 ||| NNP
Optical  ||| S:581 E:589 ||| NNP
Coherence  ||| S:589 E:599 ||| NNP
Tomography  ||| S:599 E:610 ||| NNP
( ||| S:610 E:611 ||| -LRB-
SD-OCT ||| S:611 E:617 ||| NNP
) ||| S:617 E:618 ||| -RRB-
,  ||| S:618 E:620 ||| ,
Visual  ||| S:620 E:627 ||| NNP
Evoked  ||| S:627 E:634 ||| NNP
Potentials  ||| S:634 E:645 ||| NNP
( ||| S:645 E:646 ||| -LRB-
VEP ||| S:646 E:649 ||| NNP
) ||| S:649 E:650 ||| -RRB-
,  ||| S:650 E:652 ||| ,
full-field  ||| S:652 E:663 ||| NNP
Electroretinography  ||| S:663 E:683 ||| NNP
( ||| S:683 E:684 ||| -LRB-
ERG ||| S:684 E:687 ||| NNP
) ||| S:687 E:688 ||| -RRB-
,  ||| S:688 E:690 ||| ,
multifocal  ||| S:690 E:701 ||| VBG
ERG  ||| S:701 E:705 ||| NNP
( ||| S:705 E:706 ||| -LRB-
mfERG ||| S:706 E:711 ||| NNP
) ||| S:711 E:712 ||| -RRB-
,  ||| S:712 E:714 ||| ,
Microperimetry  ||| S:714 E:729 ||| NNP
( ||| S:729 E:730 ||| -LRB-
MP-1 ||| S:730 E:734 ||| NNP
) ||| S:734 E:735 ||| -RRB-
,  ||| S:735 E:737 ||| ,
Standard  ||| S:737 E:746 ||| NNP
Automated  ||| S:746 E:756 ||| NNP
Perimetry  ||| S:756 E:766 ||| NNP
( ||| S:766 E:767 ||| -LRB-
SAP ||| S:767 E:770 ||| NNP
) ||| S:770 E:771 ||| -RRB-
,  ||| S:771 E:773 ||| ,
Fluorescein  ||| S:773 E:785 ||| NNP
Angiography  ||| S:785 E:797 ||| NNP
( ||| S:797 E:798 ||| -LRB-
FA ||| S:798 E:800 ||| NNP
)  ||| S:800 E:802 ||| -RRB-
and  ||| S:802 E:806 ||| CC
Indocyanine  ||| S:806 E:818 ||| NNP
Green  ||| S:818 E:824 ||| NNP
Angiography  ||| S:824 E:836 ||| NNP
( ||| S:836 E:837 ||| -LRB-
ICG ||| S:837 E:840 ||| NNP
) ||| S:840 E:841 ||| -RRB-
.  ||| S:841 E:843 ||| .
The  ||| S:843 E:847 ||| DT
research  ||| S:847 E:856 ||| NN
was  ||| S:856 E:860 ||| VBD
conducted  ||| S:860 E:870 ||| VBN
through  ||| S:870 E:878 ||| IN
a  ||| S:878 E:880 ||| DT
review  ||| S:880 E:887 ||| NN
of  ||| S:887 E:890 ||| IN
past  ||| S:890 E:895 ||| JJ
and  ||| S:895 E:899 ||| CC
recent  ||| S:899 E:906 ||| JJ
literature ||| S:906 E:916 ||| NN
.  ||| S:916 E:918 ||| .
